| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/07/2011 | CN102174550A Recombinant ubiquitin ligase PTB-U-box fusion gene and expression vector and application thereof |
| 09/07/2011 | CN102174521A Human ribosomal protein molecules hRrp15p and preparation method and application thereof |
| 09/07/2011 | CN102174516A Molecular target for diagnosing and treating nasopharyngeal cancer related with Epstein-Barr virus (EBV) infection and application thereof |
| 09/07/2011 | CN102174514A Double-stranded siRNA (Small Interfering Ribonucleic Acid) for suppressing Hmga2 gene expression and application thereof |
| 09/07/2011 | CN102174479A Oncolytic virus for targeted treatment of human tumors and application thereof |
| 09/07/2011 | CN102174478A Photosensitizer binding protein/polypeptide and application thereof to photodynamic gene therapy |
| 09/07/2011 | CN102174469A Method for effectively culturing tumor infiltrating lymphocytes (TILs) |
| 09/07/2011 | CN102174414A Application of new morchella costata M8-13 liquid fermentation substance to development of health-care products and medicaments |
| 09/07/2011 | CN102174119A Selenized carrageenan and preparation method thereof |
| 09/07/2011 | CN102174117A Method for preparing Stachys floridana schuttl.Exbent. polysaccharide with antitumor activity |
| 09/07/2011 | CN102174108A Internalizing anti-cd74 antibodies and methods of use |
| 09/07/2011 | CN102174106A Anti-Met humanized Fab, anti-Met humanized Fab and doxorubicin conjugate and preparation method and application of anti-Met humanized Fab and doxorubicin conjugate |
| 09/07/2011 | CN102174105A Antibodies directed to her-3 and uses thereof |
| 09/07/2011 | CN102174097A Actinoporin and application thereof |
| 09/07/2011 | CN102174096A Ciona intestinalis polypeptide and preparation method thereof |
| 09/07/2011 | CN102174084A Cyclic peptide analogues with thymosin alpha1 activity fragments and polyethylene glycol derivatives thereof |
| 09/07/2011 | CN102174078A Application of tumor cell membrane selectively penetrating peptide |
| 09/07/2011 | CN102174076A Compounds for proteasome enzyme inhibition |
| 09/07/2011 | CN102174075A Lipopeptide compound as well as compositions, preparation method and application thereof |
| 09/07/2011 | CN102174074A Inhabitors of cancer cell, T-cell and keratinocyte proliferation |
| 09/07/2011 | CN102174065A Triazolyl containing pentacyclic triterpenoid derivatives and preparation method and medicinal application thereof |
| 09/07/2011 | CN102174058A Antitumoral compounds |
| 09/07/2011 | CN102174054A 5-aryl-3-(2-pyridyl)-4,5-dihydro-pyrazole-1-thioamide Au (III) complex with anti-tumor activity |
| 09/07/2011 | CN102174046A Tetomilast polymorphs |
| 09/07/2011 | CN102174045A Tetomilast polymorphs |
| 09/07/2011 | CN102174044A Tetomilast polymorphs |
| 09/07/2011 | CN102174042A Immunosuppressant compounds and compositions |
| 09/07/2011 | CN102174035A Aromatic dihydrazide type PLK1 (Polo-like Kinase 1) inhibitor and applications thereof |
| 09/07/2011 | CN102173997A Liver cancer, gastric cancer and cervical cancer-resistant archen derivative and preparation method thereof |
| 09/07/2011 | CN102173987A New manchurian walnut bark acid and derivatives thereof, and preparation methods and medical application thereof |
| 09/07/2011 | CN102172411A Nano complex particles with targeted MR (magnetic resonance) development and photothermal therapy performance and preparation method thereof |
| 09/07/2011 | CN102172410A Construction method of targeted nano particle transmission system for cancer diagnosis and treatment |
| 09/07/2011 | CN102172408A Compositions and methods of inhibiting cell growth |
| 09/07/2011 | CN102172405A Multi-arm polymer prodrugs |
| 09/07/2011 | CN102172403A Method for treating interleukin-6 related diseases |
| 09/07/2011 | CN102172397A In vivo targeting of dendritic cells |
| 09/07/2011 | CN102172396A Application of protein factor Dmrt1 in regulating and controlling cell apoptosis |
| 09/07/2011 | CN102172394A Application of ciona intestinalis linnaeus peptides |
| 09/07/2011 | CN102172370A Method for separating decumbent corydalis tuber total alkaloid with ion exchange resin |
| 09/07/2011 | CN102172366A Method for separating total alkaloids from motherwort by using ion exchange resin |
| 09/07/2011 | CN102172365A Method for separating radix sophorae flavescentis total alkaloids by ion exchange resin |
| 09/07/2011 | CN102172363A Scf extract containing cardiac glycoside |
| 09/07/2011 | CN102172360A Colostrum extract and extraction method and application thereof |
| 09/07/2011 | CN102172359A Application of combination of adenosine and nucleoside in preparation of medicament for treating tumor |
| 09/07/2011 | CN102172357A Core 2 glcnac-t inhibitors |
| 09/07/2011 | CN102172354A Use of pentacyclic triterpene organic acid ester derivatives as glycogen phosphorylase inhibitors |
| 09/07/2011 | CN102172349A Pharmaceutical composition for treating small cell lung cancer and application, kit and package thereof |
| 09/07/2011 | CN101926826B Method for extracting active ingredients from sea horse |
| 09/07/2011 | CN101870676B 1-(2-oximido-2-phenylethyl)-3-phenyl-1H-pyrazol-5-ethyl formate derivative as well as preparation method and application thereof |
| 09/07/2011 | CN101863898B Thieno pyridinone derivative containing piperazidine and preparation method and applications thereof |
| 09/07/2011 | CN101810577B Gossypol intravenous injection fatty emulsion for curing tumors |
| 09/07/2011 | CN101757558B Chinese herbal medicine preparation for treating malignant lymphatic tumor and preparation method thereof |
| 09/07/2011 | CN101675931B New uses of acyl chloride and sulfonyl chloride derivatives in preparing anti-tumor drug |
| 09/07/2011 | CN101643509B VEGFR-2 resistant monoclonal antibody with human and mouse cross reaction as well as preparation method and application thereof |
| 09/07/2011 | CN101632795B Linnaeus penis capsules and preparation method thereof |
| 09/07/2011 | CN101628091B Pharmaceutical composition for treating leukemia or aplastic anemia |
| 09/07/2011 | CN101613414B Oleander oligosaccharide, preparation method thereof and use thereof |
| 09/07/2011 | CN101612358B Anticancer dispersing paste and preparation method thereof |
| 09/07/2011 | CN101597337B Conjugate of hydroxyalkyl starch and an active agent |
| 09/07/2011 | CN101591318B 3,5,7-trihydroxy flavone derivative, preparation method and application thereof |
| 09/07/2011 | CN101590037B Andrographolidume composition and application thereof |
| 09/07/2011 | CN101565409B Piperazidine or homopiperazine oxalyl hydrazine class compound, preparation and use thereof |
| 09/07/2011 | CN101559199B Chinese materia medica preparation for controlling tumor and adjunct tumor radiotherapy and chemotherapy and preparation method thereof |
| 09/07/2011 | CN101559124B Compound preparation for treating liver cancer and preparation method thereof |
| 09/07/2011 | CN101543625B Use of CENP-E binding protein and its coding gene in preparing medicine for suppressing tumor proliferation |
| 09/07/2011 | CN101503461B Polypeptide with liver cancer apoptosis reducing function |
| 09/07/2011 | CN101486758B Mda-7/IL-24 mutant polypeptide, and preparation and use thereof |
| 09/07/2011 | CN101474230B Total flavone extract of Conyza canadensis as well as preparation method and pharmaceutical use thereof |
| 09/07/2011 | CN101468184B Medicament for treating digestive system cancer and preparation method thereof |
| 09/07/2011 | CN101444612B Traditional Chinese medicine for treating hyperplasia of mammary glands |
| 09/07/2011 | CN101434657B Preparation and use of recombinant mtVEGF121/MAP30KDEL fusion noxioussubstance |
| 09/07/2011 | CN101429525B Antineoplastic invasion transfer function of snake venom metalloprotease inhibitors BJ46a and uses thereof |
| 09/07/2011 | CN101417105B Zedoary turmeric oil glucose injection and preparation method thereof |
| 09/07/2011 | CN101412732B Trihydrate 3-amino propyl amine ethyl phosphorothioic acid high purity stable crystal and preparation thereof |
| 09/07/2011 | CN101380461B Efficient thymosin enteric-coated tablets and thymosin for injection |
| 09/07/2011 | CN101348504B Ruthenium mixed-polypyridyl complex, preparation thereof and use as antitumor drug |
| 09/07/2011 | CN101314035B Uses of biological polyoses microcapsule |
| 09/07/2011 | CN101260136B Oestrogen derivatives as inhibitors of steroid sulphatase |
| 09/07/2011 | CN101255154B Substituted 2-indoline ketone derivatives as well as preparation method and uses thereof |
| 09/07/2011 | CN101235004B Omega-amidosulphonic acid substituted hypocrellin derivatives, preparation method and application thereof |
| 09/07/2011 | CN101213196B Derivatives of pyrido[2,3-d]pyrimidine, the preparation thereof, and the therapeutic application of the same |
| 09/07/2011 | CN101209350B Polyglutamate-medicament coupling compound with amino acid as communicating terminal |
| 09/07/2011 | CN101203493B Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them |
| 09/07/2011 | CN101156936B An administer orally mixed nucleus glycosides as well as its preparing technics |
| 09/07/2011 | CN101151020B Adjuvanting material |
| 09/07/2011 | CN101139368B Histone deacetylase inhibitor organic tin polyacid compound and preparation method thereof |
| 09/07/2011 | CN101133061B Polymorphic and amorphous forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-ce]indol-6-one |
| 09/07/2011 | CN101061101B Aroylfuranes and aroylthiophenes suitable |
| 09/07/2011 | CN101037691B CENP-E combined protein and encoding gene and application |
| 09/06/2011 | US8013156 Tie-2 modulators and methods of use |
| 09/06/2011 | US8013126 84P2A9: a prostate and testis specific protein highly expressed in prostate cancer |
| 09/06/2011 | US8013124 for stimulating the immune system, and proliferation and/or development of hematopoietic cells; production of proinflammatory cytokines |
| 09/06/2011 | US8012997 Isoindole-imide compounds, compositions, and uses thereof |
| 09/06/2011 | US8012996 Methods and composition for inhibition of angiogenesis |
| 09/06/2011 | US8012995 Pharmaceutically active sulfonamide derivatives |
| 09/06/2011 | US8012991 3-(2,4-dimethoxyphenyl)-1,9-dimethyl-2-oxo-2,9-dihydro-1H-pyrido[2,3-b]indole-6-carboxylic acid; gamma-aminobutyric acid modulator; anticarcinogenic, antitumor, antiproliferative agent; amidating a 2-aminoindole with an alpha-substituted-beta-hydroxy-alkyl acrylate |
| 09/06/2011 | US8012975 Antitumoral analogs of ET-743 |
| 09/06/2011 | US8012966 Pyrrolo [3,2-c] pyridine-4-one 2-indolinone protein kinase inhibitors |
| 09/06/2011 | US8012965 e.g. 1-(2-chloro-7-methylthieno[3,2-d]pyrimidin-4-yl)-N3-(5,7-ethano-5,7,8-trihydro-6-methyl-1,6-naphthyridin-3-yl)-1H-1,2,4-triazole-3,5-diamine; angiogenesis inhibitor, antiproliferative agent |
| 09/06/2011 | US8012964 9-substituted 8-oxoadenine compound |